For research use only. Not for therapeutic Use.
Saikogenin F exhibits anti-cancer activity[1].
Saikogenin F inhibits the proliferation of A549 cells with inhibition rates of 18.81%, 47.64% and 86.01% at concentrations of 50, 70 and 90 μg/mL, respectively[1].
| Catalog Number | M061222 |
| CAS Number | 14356-59-3 |
| Synonyms | (1S,2S,4S,5R,8R,9R,10S,13S,14R,17S,18R)-9-(hydroxymethyl)-4,5,9,13,20,20-hexamethyl-24-oxahexacyclo[15.5.2.01,18.04,17.05,14.08,13]tetracos-15-ene-2,10-diol |
| Molecular Formula | C30H48O4 |
| Purity | ≥95% |
| InChI | InChI=1S/C30H48O4/c1-24(2)13-14-29-18-34-30(21(29)15-24)12-8-20-25(3)10-9-22(32)26(4,17-31)19(25)7-11-27(20,5)28(30,6)16-23(29)33/h8,12,19-23,31-33H,7,9-11,13-18H2,1-6H3/t19-,20-,21-,22+,23+,25+,26+,27-,28+,29-,30+/m1/s1 |
| InChIKey | IUBQSOTVBGNWDI-CUMBFETHSA-N |
| SMILES | CC1(CCC23COC4(C2C1)C=CC5C6(CCC(C(C6CCC5(C4(CC3O)C)C)(C)CO)O)C)C |
| Reference | [1]. Lu Shi, et al. A Potential Anti-cancer Compound Separated from the Chloroform Extract of the Chinese Medicine Formula Shenqi San. Curr Med Sci. 2020 Feb;40(1):138-144. |
